{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:09:26Z","timestamp":1790687366242,"version":"4.1.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01340","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:28:52Z","timestamp":1593185332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":96,"title":["Environmental Risk Factors for Sarcoidosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B2","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fimmu.2012.00411","article-title":"The granuloma in tuberculosis: dynamics of a host-pathogen collusion","volume":"3","author":"Ehlers","year":"2012","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/clinids\/23.1.146","article-title":"Granulomatous infections: etiology and classification","volume":"23","author":"Zumla","year":"1996","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","article-title":"Hypersensitivity pneumonitis: insights in diagnosis and pathobiology","volume":"186","author":"Selman","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1289\/ehp.96104s5945","article-title":"Chronic beryllium disease: diagnosis and management","volume":"104","author":"Rossman","year":"1996","journal-title":"Environ Health Perspect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1165\/rcmb.2002-0164PS","article-title":"Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?","volume":"27","author":"Moller","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"170112","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17","volume":"51","author":"Broos","year":"2018","journal-title":"Eur Respir J."},{"key":"B11","first-page":"83","article-title":"HLA and sarcoidosis: new pathogenetic insights","volume":"19","author":"Martinetti","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B12","first-page":"64","article-title":"Genetics","volume-title":"Sarcoidosis: European Respiratory Monograph.","author":"Du Bois","year":"2005"},{"key":"B13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1055\/s-0034-1377059","article-title":"Sarcoidosis and chronic beryllium disease: similarities and differences","volume":"35","author":"Mayer","year":"2014","journal-title":"Semin Respir Crit Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1183\/09031936.06.00112205","article-title":"Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients","volume":"27","author":"M\u00fcller-Quernheim","year":"2006","journal-title":"Eur Respir J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1164\/rccm.201002-0254OC","article-title":"Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers","volume":"183","author":"Van Dyke","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/oem.2010.064220","article-title":"Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry","volume":"68","author":"Van Dyke","year":"2011","journal-title":"Occup Environ Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1289\/ehp.96104s5969","article-title":"Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease","volume":"104","author":"Tinkle","year":"1996","journal-title":"Environ Health Perspect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","article-title":"Clinical Features of Extrapulmonary Sarcoidosis Without Lung Involvement","volume":"154","author":"James","year":"2018","journal-title":"Chest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1600-0560.2009.01309.x","article-title":"Where does the antigen of cutaneous sarcoidosis come from?","volume":"37","author":"Kurata","year":"2010","journal-title":"J Cutan Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"235142","DOI":"10.1155\/2011\/235142","article-title":"Adaptive immune responses in primary cutaneous sarcoidosis","volume":"2011","author":"Bordignon","year":"2011","journal-title":"Clin Dev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.4049\/jimmunol.1300651","article-title":"Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells","volume":"191","author":"Brinkman","year":"2013","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.humimm.2018.05.007","article-title":"A sarcoidosis clinician's perspective of MHC functional elements outside the antigen binding site","volume":"80","author":"Judson","year":"2019","journal-title":"Hum Immunol."},{"key":"B25","first-page":"125","article-title":"HLA and environmental interactions in sarcoidosis","volume":"25","author":"Rossman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1183\/13993003.01791-2015","article-title":"Specific antigen(s) in sarcoidosis: a link to autoimmunity?","volume":"47","author":"Zissel","year":"2016","journal-title":"Eur Respir J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1164\/rccm.201407-1341OC","article-title":"Proteomic profiling reveals autoimmune targets in sarcoidosis","volume":"191","author":"H\u00e4ggmark","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10354-014-0280-2","article-title":"Cancer, infection and disturbances of the integrity of tissue homeostasis: the most significant triggers for molecular mimicry and autoimmunity in dermatology?","volume":"164","author":"Tchernev","year":"2014","journal-title":"Wien Med Wochenschr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10354-014-0283-z","article-title":"Bacterial antigens and molecular mimicry: the bridging common problematic link in the pathogenesis of sarcoidosis and sarcoid-like reactions: isn't it time to wake up?","volume":"164","author":"Tchernev","year":"2014","journal-title":"Wien Med Wochenschr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA-DRB1*03(+) patients with pulmonary sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1183\/13993003.01209-2015","article-title":"T-cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis","volume":"47","author":"Grunewald","year":"2016","journal-title":"Eur Respir J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0170285","DOI":"10.1371\/journal.pone.0170285","article-title":"Proteomic analysis of kveim reagent identifies targets of cellular immunity in sarcoidosis","volume":"12","author":"Eberhardt","year":"2017","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1074\/mcp.M116.060764","article-title":"Approach for identifying human leukocyte antigen (HLA)-DR bound peptides from scarce clinical samples","volume":"15","author":"Heyder","year":"2016","journal-title":"Mol Cell Proteomics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.clim.2009.08.008","article-title":"Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis","volume":"133","author":"Wahlstr\u00f6m","year":"2009","journal-title":"Clin Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1172\/JCI32401","article-title":"Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis","volume":"117","author":"Wahlstr\u00f6m","year":"2007","journal-title":"J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4049\/jimmunol.1502011","article-title":"Beryllium-induced hypersensitivity: genetic susceptibility and neoantigen generation","volume":"196","author":"Fontenot","year":"2016","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"351852","DOI":"10.1155\/2014\/351852","article-title":"The prevalence of antinuclear antibodies in patients with sarcoidosis","volume":"2014","author":"Kobak","year":"2014","journal-title":"Autoimmune Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1073\/pnas.0501190102","article-title":"Autophagy promotes MHC class II presentation of peptides from intracellular source proteins","volume":"102","author":"Dengjel","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jtho.2018.04.031","article-title":"Sarcoidosis-like reactions induced by checkpoint inhibitors","volume":"13","author":"Gkiozos","year":"2018","journal-title":"J Thorac Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2017.05.032","article-title":"Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1\/anti-Programmed cell Death-Ligand 1 agents: a single-centre pharmacovigilance database analysis","volume":"82","author":"Le Burel","year":"2017","journal-title":"Eur J Cancer."},{"key":"B42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther Adv Chronic Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1800385","DOI":"10.1183\/13993003.00385-2018","article-title":"Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study","volume":"52","author":"Rossides","year":"2018","journal-title":"Eur Respir J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/gene.2012.48","article-title":"Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans","volume":"14","author":"Levin","year":"2013","journal-title":"Genes Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e43907","DOI":"10.1371\/journal.pone.0043907","article-title":"Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility","volume":"7","author":"Adrianto","year":"2012","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.rmed.2012.08.009","article-title":"BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis","volume":"106","author":"Morais","year":"2012","journal-title":"Respir Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","article-title":"Is there any association between Sarcoidosis and infectious agents?","volume":"16","author":"Esteves","year":"2016","journal-title":"BMC Pulm Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0154716","DOI":"10.1371\/journal.pone.0154716","article-title":"Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis","volume":"11","author":"Fang","year":"2016","journal-title":"PLoS ONE."},{"key":"B49","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/1346-8138.15042","article-title":"Identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria from cutaneous sarcoidosis lesions by reverse blot hybridization assay","volume":"46","author":"Lee","year":"2019","journal-title":"J Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4103\/0255-0857.209569","article-title":"Levels of circulating immune complexes containing Mycobacterium Tuberculosis-specific antigens in pulmonary tuberculosis and sarcoidosis patients","volume":"35","author":"Goyal","year":"2017","journal-title":"Indian J Med Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","article-title":"Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets","volume":"55","author":"Rotsinger","year":"2016","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J Clin Microbiol."},{"key":"B53","first-page":"25","article-title":"Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study","volume":"21","author":"Milman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J Exp Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.4049\/jimmunol.181.12.8784","article-title":"T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1128\/IAI.00732-06","article-title":"Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis","volume":"75","author":"Drake","year":"2007","journal-title":"Infect Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1128\/IAI.00142-09","article-title":"Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis","volume":"77","author":"Oswald-Richter","year":"2009","journal-title":"Infect Immun."},{"key":"B58","first-page":"251","article-title":"Bacteriological investigation on biopsy specimens from patients with sarcoidosis","volume":"48","author":"Homma","year":"1978","journal-title":"Jpn J Exp Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0174-3031(84)80032-3","article-title":"Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes","volume":"256","author":"Abe","year":"1984","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A."},{"key":"B60","doi-asserted-by":"publisher","first-page":"15226","DOI":"10.1038\/s41598-017-15710-0","article-title":"Immunohistochemical detection of propionibacterium acnes in the retinal granulomas in patients with ocular sarcoidosis","volume":"7","author":"Nagata","year":"2017","journal-title":"Sci Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0192408","DOI":"10.1371\/journal.pone.0192408","article-title":"Propionibacterium acnes-derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis","volume":"13","author":"Suzuki","year":"2018","journal-title":"PLoS ONE."},{"key":"B62","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10875-007-9080-4","article-title":"Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis","volume":"27","author":"Hajizadeh","year":"2007","journal-title":"J Clin Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1128\/JCM.01433-06","article-title":"Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis","volume":"44","author":"Dubaniewicz","year":"2006","journal-title":"J Clin Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1365-2249.2007.03510.x","article-title":"Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells","volume":"150","author":"Carlisle","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"B65","first-page":"257","article-title":"Alveolar lymphocyte proliferation induced by Propionibacterium acnes in sarcoidosis patients","volume":"40","author":"Nakata","year":"1986","journal-title":"Acta Med Okayama."},{"key":"B66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.resinv.2012.07.001","article-title":"Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis","volume":"50","author":"Furusawa","year":"2012","journal-title":"Respir Investig."},{"key":"B67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2249.2011.04456.x","article-title":"In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis","volume":"166","author":"Ter\u010delj","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/sji.12273","article-title":"Increased antifungal antibodies in bronchoalveolar lavage fluid and serum in pulmonary sarcoidosis","volume":"81","author":"Suchankova","year":"2015","journal-title":"Scand J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s004170050078","article-title":"Seroprevalence of anti-Borrelia antibodies among patients with confirmed sarcoidosis in a region of Japan where Lyme borreliosis is endemic","volume":"236","author":"Ishihara","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B70","first-page":"220","article-title":"Detection of Borrelia burgdorferi DNA in granulomatous tissues from patients with sarcoidosis using polymerase chain reaction in situ technique","volume":"11","author":"Xu","year":"1996","journal-title":"Chin Med Sci J."},{"key":"B71","first-page":"93","article-title":"Borrelia burgdorferi DNA in biological samples from patients with sarcoidosis using the polymerase chain reaction technique","volume":"10","author":"Lian","year":"1995","journal-title":"Chin Med Sci J."},{"key":"B72","first-page":"201","article-title":"Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis","volume":"30","author":"Drake","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamadermatol.2013.4646","article-title":"Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study","volume":"149","author":"Drake","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamadermatol.2013.2977","article-title":"Oral minocycline in treatment of cutaneous sarcoidosis","volume":"149","author":"Steen","year":"2013","journal-title":"JAMA Dermatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/archderm.137.1.69","article-title":"The use of tetracyclines for the treatment of sarcoidosis","volume":"137","author":"Bachelez","year":"2001","journal-title":"Arch Dermatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10067-008-0903-3","article-title":"Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?","volume":"27","author":"Miyazaki","year":"2008","journal-title":"Clin Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1752-1947-8-15","article-title":"Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report","volume":"8","author":"Takemori","year":"2014","journal-title":"J Med Case Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1753465811401648","article-title":"Antifungal medication is efficient in the treatment of sarcoidosis","volume":"5","author":"Tercelj","year":"2011","journal-title":"Ther Adv Respir Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-019-0537-6","article-title":"Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis","volume":"26","author":"Inaoka","year":"2019","journal-title":"J Biomed Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fimmu.2018.00052","article-title":"Sensing bacterial-induced DNA damaging effects via natural killer group 2 member D immune receptor: from dysbiosis to autoimmunity and carcinogenesis","volume":"9","author":"Espinoza","year":"2018","journal-title":"Front Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mib.2018.07.003","article-title":"Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery","volume":"44","author":"Kriss","year":"2018","journal-title":"Curr Opin Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1590\/s1806-37562017000000209","article-title":"The pulmonary microbiome: challenges of a new paradigm","volume":"44","author":"Costa","year":"2018","journal-title":"J Bras Pneumol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1800810","DOI":"10.1183\/13993003.00810-2018","article-title":"Evaluation of the airway microbiome in nontuberculous mycobacteria disease","volume":"52","author":"Sulaiman","year":"2018","journal-title":"Eur Respir J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/thoraxjnl-2012-202917","article-title":"Microbial communities in the respiratory tract of patients with interstitial lung disease","volume":"68","author":"Garzoni","year":"2013","journal-title":"Thorax."},{"key":"B85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1164\/rccm.201705-0891OC","article-title":"Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples","volume":"197","author":"Clarke","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1600746","DOI":"10.1183\/13993003.00746-2016","article-title":"Atopobium and Fusobacterium as novel candidates for sarcoidosis-associated microbiota","volume":"50","author":"Zimmermann","year":"2017","journal-title":"Eur Respir J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40168-016-0206-x","article-title":"The lung microbiota in early rheumatoid arthritis and autoimmunity","volume":"4","author":"Scher","year":"2016","journal-title":"Microbiome."},{"key":"B88","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/oxfordjournals.aje.a114313","article-title":"The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival","volume":"123","author":"Henke","year":"1986","journal-title":"Am J Epidemiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1440-1843.2007.01062.x","article-title":"Seasonality of the onset of symptoms, tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis","volume":"12","author":"Demirkok","year":"2007","journal-title":"Respirology."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1183\/09031936.98.12051197","article-title":"Seasonal clustering of sarcoidosis presenting with erythema nodosum","volume":"12","author":"Wilsher","year":"1998","journal-title":"Eur Respir J."},{"key":"B91","first-page":"153","article-title":"Epidemiology of sarcoidosis in Catalonia: 1979-1989","volume":"13","author":"Fit\u00e9","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B92","first-page":"241","article-title":"Seasonality of sarcoidosis: the 'heat' is on","volume":"30","author":"Gupta","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1136\/thoraxjnl-2016-209032","article-title":"Seasonal variation in incidence of sarcoidosis: a population-based study, 1976-2013","volume":"71","author":"Ungprasert","year":"2016","journal-title":"Thorax."},{"key":"B94","first-page":"111","article-title":"Sarcoidosis in Ireland: regional differences in prevalence and mortality from 1996-2005","volume":"27","author":"Nicholson","year":"2010","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B95","first-page":"85","article-title":"Sarcoidosis and tuberculosis: epidemiological similarities and dissimilarities. A review of a series of studies in a Japanese work population. (1941-1996) and the general population (1959-1984)","volume":"21","author":"Hosoda","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/milmed\/165.8.630","article-title":"Risk factors for sarcoidosis hospitalization among U.S. Navy and Marine Corps personnel, 1981 to 1995","volume":"165","author":"McDonough","year":"2000","journal-title":"Mil Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/oxfordjournals.aje.a009998","article-title":"Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators","volume":"150","author":"Kajdasz","year":"1999","journal-title":"Am J Epidemiol."},{"key":"B98","first-page":"55","article-title":"Epidemiology of sarcoidosis recorded in 2006-2010 in the Silesian voivodeship on the basis of routine medical reporting","volume":"21","author":"Kowalska","year":"2014","journal-title":"Ann Agric Environ Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1183\/09031936.00197808","article-title":"Prevalence of sarcoidosis in Switzerland is associated with environmental factors","volume":"35","author":"Deubelbeiss","year":"2010","journal-title":"Eur Respir J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1378\/chest.116.5.1183","article-title":"The incidence, prevalence, and severity of sarcoidosis in New York City firefighters","volume":"116","author":"Prezant","year":"1999","journal-title":"Chest."},{"key":"B101","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1164\/ajrccm\/148.4_Pt_1.974","article-title":"Investigation of a unique time-space cluster of sarcoidosis in firefighters","volume":"148","author":"Kern","year":"1993","journal-title":"Am Rev Respir Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1378\/chest.126.5.1431","article-title":"Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001","volume":"126","author":"Gorham","year":"2004","journal-title":"Chest."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/01.jom.0000155711.88781.91","article-title":"Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS)","volume":"47","author":"Barnard","year":"2005","journal-title":"J Occup Environ Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1378\/chest.123.5.1527","article-title":"Occupational risk factors for sarcoidosis in African-American siblings","volume":"123","author":"Kucera","year":"2003","journal-title":"Chest."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e016839","DOI":"10.1136\/bmjopen-2017-016839","article-title":"Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study","volume":"7","author":"Vihlborg","year":"2017","journal-title":"BMJ Open."},{"key":"B107","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/occmed\/kqz118","article-title":"Silica dust and sarcoidosis in Swedish construction workers","volume":"69","author":"Jonsson","year":"2019","journal-title":"Occup Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ajim.23030","article-title":"Granulomatous lung disease in two workers making light bulbs","volume":"62","author":"Ronsmans","year":"2019","journal-title":"Am J Ind Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11083-004-2862-x","article-title":"Photocopier exposure and risk of sarcoidosis in African-American sibs","volume":"21","author":"Rybicki","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest."},{"key":"B111","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/rmed.2000.0827","article-title":"Association of man-made mineral fibre exposure and sarcoidlike granulomas","volume":"94","author":"Drent","year":"2000","journal-title":"Respir Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1047-2797(00)00179-4","article-title":"A current assessment of rurally linked exposures as potential risk factors for sarcoidosis","volume":"11","author":"Kajdasz","year":"2001","journal-title":"Ann Epidemiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/1756-0500-6-371","article-title":"Familial summer-type hypersensitivity pneumonitis in Japan: two case reports and review of the literature","volume":"6","author":"Nakajima","year":"2013","journal-title":"BMC Res Notes."},{"key":"B114","unstructured":"Granulomatous pneumonitis and mediastinal lymphadenopathy due to photocopier toner dust690\n            ArmbrusterC\n            DekanG\n            HovorkaA\n          10.1016\/S0140-6736(05)65119-78782783Lancet.3481996"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1183\/13993003.00477-2016","article-title":"Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden","volume":"48","author":"Arkema","year":"2016","journal-title":"Eur Respir J."},{"key":"B116","first-page":"112","article-title":"An epidemiological perspective of the pathology and etiology of sarcoidosis","volume":"33","author":"Sawahata","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0141076814562718","article-title":"The environment and disease: association or causation? (1965)","volume":"108","author":"Hill","year":"2015","journal-title":"J R Soc Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/jn\/136.4.1126","article-title":"Vitamin D and African Americans","volume":"136","author":"Harris","year":"2006","journal-title":"J Nutr."},{"key":"B119","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0954-6111(03)00127-6","article-title":"Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients","volume":"97","author":"Yanardag","year":"2003","journal-title":"Respir Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00441-016-2526-3","article-title":"Animal models of sarcoidosis","volume":"367","author":"Hu","year":"2017","journal-title":"Cell Tissue Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/nano4020508","article-title":"Carbon Nanotubes and Chronic Granulomatous Disease","volume":"4","author":"Barna","year":"2014","journal-title":"Nanomaterials."},{"key":"B122","doi-asserted-by":"publisher","first-page":"23858","DOI":"10.3390\/ijms141223858","article-title":"Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation","volume":"14","author":"Barna","year":"2013","journal-title":"Int J Mol Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcpa.2012.06.011","article-title":"Urease and Helicobacter spp. antigens in pulmonary granuloma","volume":"148","author":"Herndon","year":"2013","journal-title":"J Comp Pathol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1165\/rcmb.2009-0350OC","article-title":"Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide","volume":"44","author":"Swaisgood","year":"2011","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1165\/rcmb.2016-0035OC","article-title":"Induction of pulmonary granuloma formation by propionibacterium acnes is regulated by MyD88 and Nox2","volume":"56","author":"Werner","year":"2017","journal-title":"Am J Respir Cell Mol Biol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:28:59Z","timestamp":1593185339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":126,"alternative-id":["10.3389\/fimmu.2020.01340"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01340","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"article-number":"1340"}}